Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical Stage I-II uterine serous carcinoma

European Journal of Gynaecological Oncology

Volumn 33, Issue 5, 2012, Pages 449-454

  Robbins, J R ^a   Siddiqui, M S ^a   Al Wahab, Z ^b   Laser, B ^a   Lu, M ^a   Ali Fehmi, R ^b   Munkarah, A ^a   Elshaikh, M A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Brachytherapy; Endometrial carcinoma; Radiation treatment; Serous

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODAL CHEMOTHERAPY; OVARIECTOMY; OVERALL SURVIVAL; PELVIS EXTERNAL BEAM RADIOTHERAPY; RADIATION DOSE; RADIOTHERAPY; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; UTERINE SEROUS CARCINOMA; UTERUS CARCINOMA; VAGINAL CUFF BRACHYTHERAPY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 84868605942     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jemal A., Siegel R., Xu J., Ward E.: "Cancer statistics 2010". CA Cancer J. Clin., 2010, 60, 277.
2. Ueda S.M., Kapp D.S., Cheung M.K., Shin J.Y., Osann K., Husain A. et al.: "Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths". Am. J. Obstet. Gynecol., 2008, 195, 218.
3. Slomovitz B.M., Burke T.W., Eifel P.J., Ramondetta L.M., Silva E.G., Jhingran A. et al.: "Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases". Gynecol. Oncol, 2003, 91, 463.
4. Goff B.A., Kato D., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G. et al.: "Uterine papillary serous carcinoma: patterns of metastatic spread". Gynecol. Oncol., 1994, 54, 264.
5. Turner B.C., Knisely J.P., Kacinski B.M., Haffty B.G., Gumbs A.A., Roberts K.B. et al.: "Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy". Int. J. Radiat. Oncol. Biol. Phys., 1998, 40, 77.
6. Havrilesky L.J., Secord A.A., Bae-Jump V., Ayeni T., Calingaert B., Clarke-Pearson D.L. et al.: "Outcomes in surgical Stage I uterine papillary serous carcinoma". Gynecol. Oncol., 2007, 105, 611.
7. rd, Straughn J.M. Jr., Cohn D.E., Gold M.A. et al.: "Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy". Gynecol. Oncol., 2003, 91, 470.
8. Fader A.N., Starks D., Gehrig P.A., Secord A.A., Frasure H.E., O'Malley D.M. et al.: "An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)". Gynecol. Oncol., 2009, 115, 244.
9. Kelly MG., O'Malley D.M., Hui P., McAlpine J., Yu H., Rutherford T.J. et al.: "Improved survival in surgical Stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy". Gynecol. Oncol., 2005, 98, 353.
10. Mehta N. Yamada S.D., Rotmensch J., Mundt A.J.: "Outcome and pattern of failure in pathologic Stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy". Int. J. Radial. Oncol. Biol. Phys., 2003, 57, 1004.
11. Alektiar K.M., Makker V., Abu-Rustum N.R., Soslow R.A., Chi D.S., Barakat R.R. et al.: "Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical Stage I-II serous endometrial cancer". Gynecol. Oncol., 2009, 112, 142.
12. Kim A., Schreiber D., Rineer J., Choi K., Rotman M.: "Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma". Int. J. Radiat. Oncol. Biol. Phys., 2011, 81, e639.
13. DuBeshter B., Estler K., Altobelli K., McDonald S., Glantz C., Angel C.: "High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer". Gynecol. Oncol., 2004, 94, 383.
14. Low J.S., Wong E.H., Tan H.S., Yap S.P., Chua E.J., Sethi V.K. et al.: "Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma". Gynecol. Oncol., 2005, 97, 171.
15. Grice J., Ek M., Greer B., Koh W.J., Muntz H.G., Cain J. et al.: "Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients". Gynecol. Oncol., 1998, 69, 69.
16. Devilee P., International Agency for Research on Cancer., World Health Organization: "Pathology and genetics of tumours of the breast and female genital organs". Lyon, IARC Press, 2003.
17. Goldberg H., Miller R.C., Abdah-Bortnyak R., Steiner M., Yildiz F., Meirovitz A. et al.: "Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)". Gynecol. Oncol., 2008, 108, 298.
18. Gehrig P.A., Groben P.A., Fowler W.C. Jr., Walton L.A., Van Le L.: "Noninvasive papillary serous carcinoma of the endometrium". Obstet. Gynecol., 2001, 97, 153.
19. Fader A.N., Drake R.D., O'Malley D.M., Gibbons H.E., Huh W.K., Havrilesky L.J. et al:. "Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in Stage I uterine papillary serous carcinoma". Cancer, 2009, 115, 2119.
20. Elit L., Kwon J., Bentley J., Trim K., Ackerman I., Carey M.: "Optimal management for surgically Stage I serous cancer of the uterus". Gynecol. Oncol., 2004, 92, 240.
21. Al-Wahab Z., Ali-Fehmi R., Cote M.L., Elshaikh M.A., Ibrahim D.R., Semaan A. et al.: "The impact of race on survival in uterine serous carcinoma: a hospital-based study". Gynecol. Oncol., 2011, 121, 577.
22. Sherman M.E., Devesa S.S.: "Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus". Cancer, 2003, 98, 176.